Abstract
Renal grafts from hepatitis C virus-positive deceased donors, which were once discarded, can now be transplanted into recipients and treated posttransplant due to the emergence of direct-acting antivirals, significantly improving wait list time and organ shortages. Here, we compared outcomes in hepatitis C virus-positive patients who received kidneys from hepatitis C virus-positive versus -negative donors. In this single-center retrospective study, we divided 52 kidney transplant recipients who were viremic for hepatitis C virus pretransplant into 2 groups based on donors' hepatitis C virus serostatus (positive/negative). Demographics, time to transplant, efficacy of direct-acting antivirals, rejection episodes, immunosuppression adjustments, and renal function were assessed in both groups. Our cohort included 50 patients receiving kidneys from deceased donors and 2 from living donors (1 related, 1 unrelated). Recipients of hepatitis C virus-positive kidneys had significantly less wait list time (36 days) than recipients of hepatitis C virus-negative kidneys (806 days; P < .001). All recipients responded well to direct-acting antivirals, with both groups showing similar sustained virologic response rates that were comparable to...Continue Reading
References
Jun 15, 1997·Transplantation·J M MoralesJ L Rodicio
Apr 1, 1998·Transplantation·C LegendreS Pol
Sep 12, 1998·Transplantation·T HanafusaS Nagano
Dec 24, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P MathurinM O Bitker
Sep 6, 2000·Kidney International·H U Meier-KriescheB Kaplan
Oct 22, 2003·Journal of the American Society of Nephrology : JASN·Kevin C AbbottThomas G Peters
Jan 9, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Ihab M MahmoudMohamed A Sobh
Apr 28, 2005·Nephron. Clinical Practice·Ihab M MahmoudMohamed A Ghoneim
May 13, 2005·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Fabrizio FabriziGareth Dulai
Sep 8, 2006·European Journal of Gastroenterology & Hepatology·Patrizia BurraSavina Maria Luciana Aversa
Jul 5, 2007·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J M GloorF G Cosio
Jul 30, 2008·Journal of Hepatology·Paul Martin, Fabrizio Fabrizi
Apr 14, 2010·Transplantation·Hung-Tien KuoSuphamai Bunnapradist
Jun 8, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K EllingsonUNKNOWN Organ Procurement Organization Nucleic Acid Testing Yield Project Team
Apr 11, 2014·Journal of Viral Hepatitis·F FabriziP Messa
Oct 24, 2014·Transplantation·Joseph R ScaleaJohn C LaMattina
Apr 24, 2015·Journal of Viral Hepatitis·H ParkZ Younossi
Jul 23, 2015·The New England Journal of Medicine·Peter P ReeseDavid S Goldberg
Aug 28, 2015·Advances in Chronic Kidney Disease·Anu Gupta, Richard J Quigg
Mar 2, 2016·Current Opinion in Organ Transplantation·Tianyan Chen, Norah A Terrault
Nov 15, 2016·Annals of Internal Medicine·Massimo ColomboStanislas Pol
Feb 28, 2017·Clinical Transplantation·Amilcar L MoralesColeman Smith
Mar 24, 2017·Transplant International : Official Journal of the European Society for Organ Transplantation·Kalyan R BhamidimarriDavid Roth
May 2, 2017·The New England Journal of Medicine·David S GoldbergPeter P Reese
Jul 18, 2017·Clinical Transplantation·Gaurav GuptaRichard Sterling
Oct 23, 2017·Kidney International·Deirdre SawinskiJayme E Locke
Nov 11, 2017·Clinical Epidemiology·Sofie HallagerNina Weis
Apr 7, 2018·Journal of Viral Hepatitis·T WisløffH Kløvstad
Jan 27, 2019·Kidney International Supplements